Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Athira Pharma, Inc. (ATHA)
Company Research
Source: Yahoo! Finance
A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Stryker is one of 1062 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group. The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Stryker is currently sporting a Zacks Rank of #2 (Buy). Over the past three months, the Zacks Consensus Estimate for SYK's full-year earnings has moved 2.9% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. Based on the latest available data, SYK has gaine
Show less
Read more
Impact Snapshot
Event Time:
ATHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATHA alerts
High impacting Athira Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
ATHA
News
- One Athira Pharma Insider Raised Their Stake In The Previous Year [Yahoo! Finance]Yahoo! Finance
- Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical OfficerGlobeNewswire
- Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease [Yahoo! Finance]Yahoo! Finance
- Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s DiseaseGlobeNewswire
ATHA
Earnings
- 11/9/23 - In-Line
ATHA
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 3
- 4/9/24 - Form ARS
- ATHA's page on the SEC website